Motion Sickness Severity and Sensorimotor Performance

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-40
SponsorIstinye University

About this trial

Background: Motion sickness (MS) is a common syndrome characterized by autonomic and behavioral symptoms, such as nausea and dizziness, resulting from exposure to motion stimuli. Its pathophysiology is closely linked to sensory conflict and postural instability theories. While previous studies suggest that postural control, proprioception, and reaction times are affected in individuals susceptible to MS, there is a lack of comprehensive, comparative research evaluating all these parameters concurrently within the same cohort using standardized methods. Objective: This study aims to systematically measure balance, proprioceptive sensitivity, coordination, and reaction time parameters, and quantitatively analyze their relationship with motion sickness severity. Methodology: In this prospective, cross-sectional study, at least 41 participants aged 18-40 with motion sickness will be recruited. Participants will undergo motion sickness susceptibility and severity grading using the Motion Sickness Susceptibility Questionnaire Short Form (MSSQ-SF) and the Graybiel Scale. Objective assessments will include static and dynamic balance testing (ProKin®), knee joint position sense (Clinometer app), manual dexterity and dynamic balance coordination (Nine-Hole Peg Test, Tandem Walk, Romberg Test), and upper/lower extremity reaction time measurements (BlazePod system).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Individuals aged between 18 and 40 years.

Diagnosed with motion sickness according to the Motion Sickness -Susceptibility Questionnaire Short Form (MSSQ-SF).

Normal hearing acuity.

No history of acute or chronic vestibular disease, other than motion sickness.

Disqualifiers

Presence of any physical or orthopedic problem that could interfere with testing.

History of acute or chronic instability, unsteadiness, or vertigo.

Severe visual impairment.

History of prior ear surgery.

Trial population

The study population consists of adult individuals aged between 18 and 40 years who exhibit susceptibility to motion sickness.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Standardized Sensorimotor Assessment and Motion Sickness Provocation Protocol

    Other intervention

    Participants will undergo a standardized battery of sensorimotor assessments, including static/dynamic balance tracking, knee joint position sense testing, manual dexterity/coordination tasks, and upper/lower extremity reaction time measurements, alongside a controlled motion sickness provocation session using a randomized chair-rotation protocol."

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Motion Sickness Severity (Graybiel Score)

Used to grade the clinical severity of acute motion sickness symptoms (including nausea, cold sweating, increased salivation, and dizziness) following a randomized chair-rotation provocation protocol. 0 (Minimum) to 50 points (Maximum). Higher scores indicate greater symptom severity, representing a worse clinical outcome (scores of 16 or above designate frank sickness).

Time frame
1 hour
2

Static Balance

Evaluated objectively using the ProKin® computerized balance system. Participants stand on the platform under conditions: double-leg with eyes open.

Time frame
1 hour
3

Dynamic Balance Performance

Evaluated using the ProKin® system.

Time frame
1 hour

Secondary outcomes

1

Knee Joint Proprioception

Evaluated in supine and prone positions, targeting knee angles of 15°, 30°, 60°, and 90° using the Clinometer digital inclinometer smartphone application.

Time frame
1 hour
2

Nine-Hole Peg Test (9HPT) Completion Time

Used to assess upper extremity dexterity and fine motor coordination. Participants place nine pegs into the holes one by one and then remove them as quickly as possible.

Time frame
1 hour
3

Tandem Walk Test Error Count

Participants walk barefoot along a straight line for 10 steps, placing the heel of one foot directly against the toe of the other foot with arms relaxed at their sides.

Time frame
1 hour
4

Visual Reaction Time

Evaluated using the mobile application-based BlazePod.

Time frame
1 hour

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: